KARAKAYA, M. F. Et Al. 2017. Discontinuation of lamivudine treatment in HBeAg-negative chronic hepatitis B: a pilot study with long-term follow-up. ANTIVIRAL THERAPY , vol.22, no.7 , 559-570.

KARAKAYA, M. F., özer, s., Kalkan, C., Tuzun, E. A., Caliskan, A., Keskin, O., ... Kabacam, G.(2017). Discontinuation of lamivudine treatment in HBeAg-negative chronic hepatitis B: a pilot study with long-term follow-up. ANTIVIRAL THERAPY , vol.22, no.7, 559-570.

KARAKAYA, MUHAMMED Et Al. "Discontinuation of lamivudine treatment in HBeAg-negative chronic hepatitis B: a pilot study with long-term follow-up," ANTIVIRAL THERAPY , vol.22, no.7, 559-570, 2017

KARAKAYA, MUHAMMED F. Et Al. "Discontinuation of lamivudine treatment in HBeAg-negative chronic hepatitis B: a pilot study with long-term follow-up." ANTIVIRAL THERAPY , vol.22, no.7, pp.559-570, 2017

KARAKAYA, M. F. Et Al. (2017) . "Discontinuation of lamivudine treatment in HBeAg-negative chronic hepatitis B: a pilot study with long-term follow-up." ANTIVIRAL THERAPY , vol.22, no.7, pp.559-570.

@article{article, author={MUHAMMED FATİH KARAKAYA Et Al. }, title={Discontinuation of lamivudine treatment in HBeAg-negative chronic hepatitis B: a pilot study with long-term follow-up}, journal={ANTIVIRAL THERAPY}, year=2017, pages={559-570} }